JAMES HEALY

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JAMES HEALY:

Company Role Class Num Shares Value Price $ Report Date Ownership
Natera, Inc. Director Common Stock 1,550,280 $219,225,094 $141.41 25 Apr 2025 by Sofinnova Venture Partners IX, L.P.
BioAge Labs, Inc. Director Common Stock 2,227,124 $40,088,232 $18.00 27 Sep 2024 Sofinnova Venture Partners XI, L.P.
Rapport Therapeutics, Inc. Director Common Stock 1,863,327 $18,596,003 $9.98 01 Jul 2024 By Sofinnova Venture Partners XI, L.P.
Natera, Inc. Director Common Stock 46,260 $6,541,626 $141.41 25 Apr 2025 Direct
ArriVent Biopharma, Inc. Director Common Stock 1,696,752 $6,193,145 $3.65 30 Jan 2024 Sofinnova Venture Partners XI, L.P.
BioAge Labs, Inc. Director Common Stock 26,497 $476,946 $18.00 27 Sep 2024 CRESTLINE SUMMIT PINNACLE MASTER, L.P.
Rapport Therapeutics, Inc. Director Common Stock 40,851 $407,693 $9.98 01 Jul 2024 By Crestline Summit Master, SPC - PEAK SP
Rapport Therapeutics, Inc. Director Common Stock 39,661 $395,817 $9.98 01 Jul 2024 By CRESTLINE SUMMIT PINNACLE MASTER, L.P.
BioAge Labs, Inc. Director Common Stock 21,814 $392,652 $18.00 27 Sep 2024 Crestline Summit Master, SPC - PEAK SP
Rapport Therapeutics, Inc. Director Common Stock 33,114 $330,478 $9.98 01 Jul 2024 By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP
BioAge Labs, Inc. Director Common Stock 18,353 $330,354 $18.00 27 Sep 2024 CRESTLINE SUMMIT MASTER, SPC - CRESTLINE SUMMIT APEX SP
BioAge Labs, Inc. Director Common Stock 11,113 $200,034 $18.00 27 Sep 2024 Sofinnova Synergy Master Fund LP
Rapport Therapeutics, Inc. Director Common Stock 18,641 $186,037 $9.98 01 Jul 2024 By Sofinnova Synergy Master Fund LP
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 By Sofinnova Management X, L.P.
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 By Sofinnova Synergy Master Fund, LP
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 By Sofinnova Venture Partners X, LP
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 18 Mar 2024 Direct
Karuna Therapeutics, Inc. Director Option (right to buy) 0 $0 $92.30 18 Mar 2024 Direct
Y-mAbs Therapeutics, Inc. Director Common Stock 0 $0 $8.52 16 Sep 2025 Direct
Y-mAbs Therapeutics, Inc. Director Common Stock 0 $0 $8.60 16 Sep 2025 Indirect
Coherus BioSciences, Inc. Director Stock Option (Right to Buy) 27,000 07 Jan 2022 Direct
BioAge Labs, Inc. Director Stock Option (Right to Buy) 22,000 05 Jun 2025 Direct
Bolt Biotherapeutics, Inc. Director Stock Option (Right to Buy) 22,000 12 Jun 2024 Direct
Rapport Therapeutics, Inc. Director Stock Option (Right to Buy) 21,850 17 Jun 2025 Direct
ArriVent Biopharma, Inc. Director Series B Preferred Stock 0 30 Jan 2024 Sofinnova Venture Partners XI, L.P.
BioAge Labs, Inc. Director Series D Preferred Stock 0 27 Sep 2024 Sofinnova Venture Partners XI, L.P.
CinCor Pharma, Inc. Director, 10%+ Owner Common Stock 0 $28.75 28 Nov 2022 By Sofinnova Synergy Master Fund, LP
CinCor Pharma, Inc. Director, 10%+ Owner Common Stock 0 $28.75 24 Feb 2023 By Sofinnova Venture Partners X, L.P.
CinCor Pharma, Inc. Director, 10%+ Owner Common Stock 0 $28.75 24 Feb 2023 Direct
Y-mAbs Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 16 Sep 2025 Direct

Insider Reports Filed by JAMES HEALY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
YMAB Y-mAbs Therapeutics, Inc. 16 Sep 2025 11 -$19,142,577 4 Director 18 Sep 2025, 20:59
YMAB Y-mAbs Therapeutics, Inc. 30 Jun 2025 2 $0 4 Director 02 Jul 2025, 16:20
RAPP Rapport Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:15
BIOA BioAge Labs, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:46
NTRA Natera, Inc. 25 Apr 2025 1 $0 4 Director 29 Apr 2025, 20:35
NTRA Natera, Inc. 31 Jan 2025 1 $0 4 Director 04 Feb 2025, 21:15
NTRA Natera, Inc. 25 Oct 2024 1 $0 4 Director 29 Oct 2024, 21:05
BIOA BioAge Labs, Inc. 25 Sep 2024 8 +$11,999,970 4 Director 27 Sep 2024, 16:22
BIOA BioAge Labs, Inc. 25 Sep 2024 0 $0 3 Director 25 Sep 2024, 16:53
NTRA Natera, Inc. 26 Jul 2024 1 $0 4 Director 30 Jul 2024, 21:05
RAPP Rapport Therapeutics, Inc. 01 Jul 2024 12 +$1,079,575 4 Director 03 Jul 2024, 20:04
NTRA Natera, Inc. 28 Jun 2024 1 $0 4 Director 02 Jul 2024, 21:05
BOLT Bolt Biotherapeutics, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 18:50
YMAB Y-mAbs Therapeutics, Inc. 11 Jun 2024 2 $0 4 Director 13 Jun 2024, 21:01
RAPP Rapport Therapeutics, Inc. 10 Jun 2024 7 +$9,500,008 4 Director 10 Jun 2024, 19:38
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Director 06 Jun 2024, 19:03
NTRA Natera, Inc. 26 Apr 2024 1 $0 4 Director 30 Apr 2024, 20:35
/report/000114036124013925-healy-james-2024-03-18 Karuna Therapeutics, Inc. 18 Mar 2024 9 -$472,763,849 4 Director 18 Mar 2024, 16:30
AVBP ArriVent Biopharma, Inc. 30 Jan 2024 3 +$7,999,992 4 Director 31 Jan 2024, 16:10
NTRA Natera, Inc. 26 Jan 2024 1 +$16,841 4 Director 30 Jan 2024, 20:05
AVBP ArriVent Biopharma, Inc. 25 Jan 2024 0 $0 3 Director 25 Jan 2024, 20:37
NTRA Natera, Inc. 13 Dec 2023 1 -$37,835,000 4 Director 22 Dec 2023, 14:21
NTRA Natera, Inc. 27 Oct 2023 1 +$16,870 4 Director 31 Oct 2023, 21:05
NTRA Natera, Inc. 28 Jul 2023 1 +$15,901 4 Director 01 Aug 2023, 21:05
NTRA Natera, Inc. 30 Jun 2023 2 $0 4 Director 05 Jul 2023, 21:05
/report/000095017023029414-healy-james-2023-06-20 Karuna Therapeutics, Inc. 20 Jun 2023 2 $0 4 Director 22 Jun 2023, 16:16
/report/000110465923073047-healy-james-2023-06-14 Karuna Therapeutics, Inc. 14 Jun 2023 2 $0 4 Director 20 Jun 2023, 20:56
BOLT Bolt Biotherapeutics, Inc. 12 Jun 2023 1 $0 4 Director 14 Jun 2023, 17:14
YMAB Y-mAbs Therapeutics, Inc. 08 Jun 2023 2 $0 4 Director 09 Jun 2023, 18:00
NTRA Natera, Inc. 25 May 2023 2 $0 4 Director 30 May 2023, 17:05
NTRA Natera, Inc. 14 Apr 2023 1 +$15,598 4 Director 18 Apr 2023, 20:10
NTRA Natera, Inc. 13 Jan 2023 1 +$15,604 4 Director 18 Jan 2023, 20:35
/report/000110465923004364-healy-james-2023-01-12 Karuna Therapeutics, Inc. 12 Jan 2023 3 -$1,204,771 4 Director 17 Jan 2023, 19:43
/report/000120919123013481-healy-james-2022-11-28 CinCor Pharma, Inc. 28 Nov 2022 4 -$85,920 4 Director, 10%+ Owner 27 Feb 2023, 20:15
NTRA Natera, Inc. 16 Nov 2022 1 -$90,498 4 Director 18 Jan 2023, 10:12
NTRA Natera, Inc. 14 Oct 2022 1 +$15,624 4 Director 18 Oct 2022, 21:07
/report/000110465922091183-healy-james-2022-08-11 CinCor Pharma, Inc. 11 Aug 2022 2 +$15,180,000 4 Director, 10%+ Owner 15 Aug 2022, 15:45
/report/000159396822001315-healy-james-2022-08-05 Karuna Therapeutics, Inc. 05 Aug 2022 2 +$520,000 4 Director 08 Aug 2022, 17:43
/report/000120919122044741-healy-james-2022-08-05 CinCor Pharma, Inc. 05 Aug 2022 2 +$399,990 4 Director, 10%+ Owner 08 Aug 2022, 12:57
YMAB Y-mAbs Therapeutics, Inc. 15 Jul 2022 1 $0 4 Director 19 Jul 2022, 13:22
NTRA Natera, Inc. 08 Jul 2022 1 $0 4/A Director 02 Sep 2022, 20:05
/report/000110465922076722-healy-james-2022-06-29 Karuna Therapeutics, Inc. 29 Jun 2022 6 +$14,736,158 4 Director 01 Jul 2022, 13:23
/report/000159396822001146-healy-james-2022-06-15 Karuna Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:29
BOLT Bolt Biotherapeutics, Inc. 10 Jun 2022 1 $0 4 Director 10 Jun 2022, 18:13
NTRA Natera, Inc. 27 May 2022 2 $0 4 Director 01 Jun 2022, 21:05
NTRA Natera, Inc. 25 May 2022 2 $0 4 Director 27 May 2022, 21:46
/report/000110465922046068-healy-james-2022-04-01 Karuna Therapeutics, Inc. 01 Apr 2022 1 +$6,081 4 Director 14 Apr 2022, 16:46
BOLT Bolt Biotherapeutics, Inc. 24 Mar 2022 1 $0 4 Director 28 Mar 2022, 15:18
/report/000120919122003192-healy-james-2022-01-11 CinCor Pharma, Inc. 11 Jan 2022 4 +$5,200,000 4 Director, 10%+ Owner 13 Jan 2022, 15:33
CHRS Coherus BioSciences, Inc. 07 Jan 2022 1 $0 4/A Director 11 Feb 2022, 15:14
/report/000120919122002279-healy-james-2022-01-06 CinCor Pharma, Inc. 06 Jan 2022 0 $0 3 Director, 10%+ Owner 06 Jan 2022, 19:53
CHRS Coherus BioSciences, Inc. 27 Sep 2021 3 -$7,250,063 4 Director 29 Sep 2021, 20:18
NTRA Natera, Inc. 22 Jul 2021 1 +$271,200 4 Director 26 Jul 2021, 18:11
/report/000110465921089894-healy-james-2021-07-02 Karuna Therapeutics, Inc. 02 Jul 2021 1 +$74,923 4 Director 07 Jul 2021, 18:48
/report/000159396821001683-healy-james-2021-06-16 Karuna Therapeutics, Inc. 16 Jun 2021 1 $0 4 Director 23 Jun 2021, 16:31
NTRA Natera, Inc. 28 May 2021 4 $0 4 Director 02 Jun 2021, 20:05
YMAB Y-mAbs Therapeutics, Inc. 10 Jun 2020 1 $0 4 Director 14 Jun 2021, 17:04